
Neurocrine Biosciences, Inc.
USD165.11
+10.27 (+6.63%)
CEO
Kyle W. Gano
IPO Date
1996-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$155.53
Prev. Close
$154.84
Day Low
$155.12
Day High
$165.81
52W Low
$122.14
52W High
$165.81
Market Cap
$16.60B
Volume
1.94M
| 6 May 2026 |
| Piper Sandler |
| Overweight |
| Overweight |
| maintain |
| 6 May 2026 | Wedbush | Outperform | Outperform | maintain |
| 6 May 2026 | Guggenheim | Buy | Buy | maintain |
| 6 May 2026 | RBC Capital | Outperform | Outperform | maintain |
| 6 May 2026 | Morgan Stanley | Equal Weight | Equal Weight | maintain |
| 6 May 2026 | Citigroup | Buy | Buy | maintain |
| 22 Apr 2026 | Leerink Partners | Outperform | Outperform | maintain |